- Home
- SXTC vs TENX Comparison
SXTC vs TENX Comparison
Compare SXTC & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTC
- TENX
- Stock Information
- Founded
- SXTC 2005
- TENX 1967
- Country
- SXTC China
- TENX United States
- Employees
- SXTC N/A
- TENX N/A
- Industry
- SXTC Biotechnology: Pharmaceutical Preparations
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- SXTC Health Care
- TENX Health Care
- Exchange
- SXTC Nasdaq
- TENX Nasdaq
- Market Cap
- SXTC 25.5M
- TENX 21.6M
- IPO Year
- SXTC 2019
- TENX N/A
- Fundamental
- Price
- SXTC $1.32
- TENX $6.08
- Analyst Decision
- SXTC
- TENX Strong Buy
- Analyst Count
- SXTC 0
- TENX 3
- Target Price
- SXTC N/A
- TENX $16.00
- AVG Volume (30 Days)
- SXTC 2.4M
- TENX 9.3K
- Earning Date
- SXTC 01-01-0001
- TENX 05-14-2025
- Dividend Yield
- SXTC N/A
- TENX N/A
- EPS Growth
- SXTC N/A
- TENX N/A
- EPS
- SXTC 20.77
- TENX N/A
- Revenue
- SXTC $1,818,404.00
- TENX N/A
- Revenue This Year
- SXTC N/A
- TENX N/A
- Revenue Next Year
- SXTC N/A
- TENX N/A
- P/E Ratio
- SXTC $0.07
- TENX N/A
- Revenue Growth
- SXTC 6.78
- TENX N/A
- 52 Week Low
- SXTC $0.95
- TENX $2.77
- 52 Week High
- SXTC $11.92
- TENX $7.89
- Technical
- Relative Strength Index (RSI)
- SXTC 41.43
- TENX 56.92
- Support Level
- SXTC $1.34
- TENX $6.00
- Resistance Level
- SXTC $1.76
- TENX $6.31
- Average True Range (ATR)
- SXTC 0.23
- TENX 0.26
- MACD
- SXTC -0.01
- TENX 0.03
- Stochastic Oscillator
- SXTC 15.71
- TENX 65.88
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.